Ultralife Corp. (ULBI) Reports Q2 EPS of $0.05
Tweet
Share
E-mailGet Alerts ULBI Hot Sheet
Price: $7.01 +2.34%
Financial Fact:
Operating income (loss): 1.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating income (loss): 1.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.05, versus ($0.08) reported last year. Revenue for the quarter came in at $19 million, versus $15.2 million reported last year.
For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Is the global equity rally broadening? UBS weighs in
- Vireo Growth completes acquisition of C21 Investments
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
